LAW CHE-LEUNG has a total of 12 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PROTAGONIST THERAPEUTICS INC, BIO DISCOVERY LTD and ZYMOGENETICS L L C.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 4 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Measuring microorganism processes | |
#6 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Law Che-Leung | 12 |
#2 | Wahl Alan F | 11 |
#3 | Mcearchern Julie | 6 |
#4 | Pestano Linda A | 3 |
#5 | Scholler Nathalie | 3 |
#6 | Petroziello Joseph M | 2 |
#7 | Yamane Andrew K | 1 |
#8 | Drachman Jonathan G | 1 |
#9 | Petroziello Joseph P | 1 |
Publication | Filing date | Title |
---|---|---|
US2012294863A1 | Anti-CD70 Antibody and Its Use for the Treatment and Prevention of Cancer and Immune Disorders | |
US2009232806A1 | Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders | |
WO2004006753A2 | Sga-72m, a cancer associated antigen, and uses thereof | |
WO03065873A2 | Sga-1m, a cancer associated antigen, and uses thereof |